UNHSystem T Performances: Annual Compound Profit 40%, Win Rate 55%, Risk Reward 2:1, 20 Years of Backtesting Data! Follow me for my Buy & Sell signals!
UNH trade ideas
Possible short on healthcareSeeing a very consistent dome pattern on the 3D chart. I'd be looking for shorts/puts either on a retest of the dome line or on a break of the support. No trade on this until I one or the other happen.
$UNH Reversal trade off strong support in UnitedHealth Possible entry level $222 = Target price $247 = Stop loss $212
P/E ratio 16.32 which is very reasonable.
Yield 1.98%
Average analyst price target $291 | Buy rating
Latest analyst commentary
Barclays analyst Steven Valiquette maintained a Buy rating on UnitedHealth yesterday and set a price target of $260.00. The company’s shares closed last Monday at $220.11, close to its 52-week low of $208.07.
According to TipRanks.com, Valiquette is a 2-star analyst with an average return of 0.7% and a 47.0% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Patterson Companies Inc, and Capital Senior Living.
Currently, the analyst consensus on UnitedHealth is a Strong Buy with an average price target of $298.45, representing a 35.6% upside. In a report issued on September 26, Morgan Stanley also maintained a Buy rating on the stock with a $294.00 price target.
Sourse Smarter analyst
Company profile
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health services business serving the broad health care marketplace, including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the health care industry. The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.
Option traders See reversal trade in UNHToday's options market seen some unusual activity In NYSE:UNH , signalling that there may be some good news on the horizon. The stock has hot some historical support and both the Stoch and RSI are showing signs of a reversal.
UNH insider sales flash a warning sign ahead of earningsUnitedHealth Group has had an incredibly strong showing this year, and right now it's priced pretty attractively at oversold level on the hourly chart. On its daily chart it's at RSI 38, nearing oversold (RSI 30) but not quite there yet. It also hasn't yet tested its August low of 220.78 or its one-year lows of 208.07 and 216.84. I suspect we'll get a bounce tomorrow from the hourly oversold level, then fall some more to the 216-220 range. At that point we should be about oversold on the daily chart and should bounce into earnings on October 15.
The average analyst price target on UNH is about 299, implying about 33% upside from the current price. Analyst estimates of UNH earnings have held steady for the past month at 3.77, significantly better than 3.41 the same quarter last year. UNH has an 8.7/10 Equity Starmine Summary Score rating. So most signs are bullish. However, company director Richard Burke sold 10,000 shares last week. Other directors also recently sold thousands of shares. All this insider selling doesn't inspire confidence for good earnings this quarter. On that basis alone, I don't think I'd hold this for anything more than a pre-earnings bounce. On the other hand, insider sellers may be responding to political risk rather than to the company's financials.
The healthcare sector is expected to report good earnings this quarter, which could make it attractive as a defensive play in an earnings recession. Healthcare is a defensive sector that usually does well when the rest of the market is down. Right now healthcare stocks are cheap, which makes them even more attractive. However, with Elizabeth Warren leading the Democratic pack, UNH's share price may continue its breakdown. Health insurance and pharmaceutical companies are at particular risk from Warren's "Medicare for All" plan, and you may be able to chart healthcare stocks' performance from now until the election as a function of Warren's popularity in the polls.
UNH Bullish Breakout to $250 Into Earnings$UNH is a safety, growth, and value play all in one. Looking for it to continue this upside breakout into earnings. Target is $248
NYSE:UNH
United Healthcare - Buy Signal or Bear Flag?Not financial advice. Do your own research. The ideas shared here are the personal opinions of the BitDoctor team. Trade at your risk.
United Healthcare has been on my radar for a shile but only since last week have I paid more attention to the support we recently had and the pivot we've seen here. I don't speak much to fundamentals, nor do I really care about news events but what I can say is the pivot we recently had is not accidental. It's a technical pivot that we've seen. Indicative of the completion of a 1-2 and then we potentially head up for a much larger 3. I am tempted to go long on UNH from here and stop at the bottom of our pivot. I see we've already closed all gaps and from a moving average standpoint, we're trading below most moving averages. This could be seen as a very bearish setup but as long as this pivot holds ($220), then we should be fine to see a move back to $280 - $300.
Trade carefully friends. If we break $220, then we're almost definitely going back to $200 and likely much lower. I just don't see that right now. I see more upside to $240 minimum. Target, though, is $281.40
<3 -CE-
Several buy signals on UNHI've been watching UNH closely ever since its big guidance upgrade on the last earnings report. The stock chose that moment to start tanking, and it's been tanking ever since. Hopefully the market has now had enough of this down trend and is ready for the stock to recover.
Zacks, one of the best-performing analytics firms, upgraded UNH today to a buy. It's got an 8.3/10 Equity StarMine Summary score. UNH also flashed a buy signal a few days ago on the reverse RSI indicator, and it's in oversold territory on the daily stochastic. There's strong support from volume in the 220-228 range, so this is a good range to buy. Below 220, we could fall to 212 or 200.
trouble ahead for UNH? Bearish divergence
crossing (and closing?) below 20MA
MA not in an upward slope anymore
UNH - Trade setupI like the break of the past few days of support right here.. BUT I do want to let it break that support back here in the circle first.. This could be a nice little money maker but could take a few days to complete once in.. Make sure you buy out at least 2 weeks maybe a month.
Long26/Jul/2019 10:06 AM
--
Long, target is 69 retrace level @ $260.
Stop at low of candle
======================
UnitedHealth trend line breakout in progressUnitedHealth is making a bullish trend line breakout in the first hour of trading. After blowout earnings and a guidance revision, UNH is a great value at this price. I intend to hold this for a while.
Choosing an entry on UNHAfter strong earnings and a guidance upgrade, I've just been waiting for an entry point on UNH .
Today we are oversold on the hourly RSI and stochastic , and I'm seeing a little bullish divergence coming in on the hourly MACD histogram. We've got support at 254.44 from the 20-day moving average, though there's not a lot of volume located here on the volume profile . I've taken a small long position here, and I'll buy more if we get down closer to 250, where there's more volume and also support from the 50-day and 200-day moving averages.
Daily UNH stock price prediction analysis19-JUL
www.pretiming.com
Investing position: In Rising section of high profit & low risk
S&D strength Trend: In the midst of an adjustment trend of downward direction box pattern price flow marked by limited rises and downward fluctuations.
Today's S&D strength Flow: Supply-Demand(S&D) strength flow appropriate to the current trend.
Forecast D+1 Candlestick Color : RED Candlestick
%D+1 Range forecast: 1.1% (HIGH) ~ -1.0% (LOW), 0.1% (CLOSE)
%AVG in case of rising: 1.6% (HIGH) ~ -0.7% (LOW), 1.4% (CLOSE)
%AVG in case of falling: 0.6% (HIGH) ~ -1.7% (LOW), -0.9% (CLOSE)
UNH selloff offers an important reminder about earnings playsThis morning I read UnitedHealth Group's earnings report and purchased some shares at about yesterday's closing price. The report was extremely positive. UnitedHealth not only beat analyst estimates, but also raised its guidance for the rest of the year. Ordinarily these results would get a big pop, but instead the stock promptly sold off to the tune of 2-3%.
This offers me an important reminder about something I knew, but had forgotten: it's not just the content of the earnings report that matters, but also the recent price action.
UNH had gained steadily for 2 months and popped 5% a few days before earnings, which implies that investor expectations were higher than analyst estimates. In fact, it's possible that the earnings result leaked early, and that this was a case of investors buying the hype and selling the news. Regardless, UNH was overbought and sitting at strong resistance level going into earnings. It didn't have a lot of room to run, so instead it corrected downward. It's still in an upward channel and should post some gains in the coming week.
By contrast, Chewy's share price has been falling recently, and after hours today it's popping despite missing analyst estimates by 1 cent per share. This suggests that investor expectations for Chewy were lower than analyst estimates. (It also shows how good a job Chewy's PR people did at framing its disappointing results in terms of a positive year-over-year improvement in the press release.)
Long UNH 3% profit beat, 13% improvement YoY, improved guidancePrevious ER was also good, but entire healthcare went down heavily 3 months ago due to "medicare for all", however, recent drug rebate proposal reversed the action and UNH should go up mid/long term.
$UNH Healthcare Breakout Go long healthcare if anything in this market. Clear breakout signal. UNH XLV CI
